Autologous Stem-Cell Transplantation for Hodgkin’s Disease: Results and Prognostic Factors in 494 Patients From the Grupo Español de Linfomas/Transplante Autólogo de Médula Ósea Spanish Cooperative GroupAnna Sureda, E. Condé, Álvaro Marchán-López et al.|Journal of Clinical Oncology|2001Cited by 233
Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin's lymphoma autografted after a first relapseAnna Sureda, E. Condé, M. Constans et al.|Annals of Oncology|2005Cited by 220
Reduced intensity conditioning allogeneic stem cell transplantation for Hodgkin's lymphoma: identification of prognostic factors predicting outcomeStephen Robinson, Anna Sureda, Carmen Canals et al.|Haematologica|2008Cited by 169
High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative GroupMarı́a Dolores Caballero, E. Condé, Josè Antonio Pérez-Simón et al.|Annals of Oncology|2002Cited by 70
Autologous stem cell transplantation for primary refractory Hodgkin’s disease: results and clinical variables affecting outcomeM. Constans, E. Condé, Anna Sureda et al.|Annals of Oncology|2003Cited by 46